 - Hormonal therapy: Patients may have had prior anticancer hormonal therapy provided it is discontinued 4 weeks prior to registration into the study; however, patients with prostate cancer with evidence of progressive disease may continue on therapy which produces medical castration eg, goserelin or leuprorelin provided this was commenced at least three months earlier 